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Key points
●● The patient and family perspective on inappropriateness of intensive care at the end of life often 
differs from the clinician’s opinion due to the nonmedical frame of mind.
●● To improve satisfaction with communication on treatment goals, consultation on patient values 
and inclusion of social constructs in addition to clinical prediction is a good start to reconcile 
differences between physician and health service users’ viewpoints.
●● During pandemics, where health systems may collapse, different admission criteria driven by the 
need to ration services may be warranted.
Educational aims
●● To explore the extent to which older patients and their families are involved in decisions about 
appropriateness of intensive care admission or treatments
●● To understand how patients or their families define inappropriate intensive care admission or 
treatments
●● To reflect on the implications of decision to admit or not to admit to the intensive care unit in the 
face of acute resource shortages during a pandemic
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The #COVID19 crisis has raised the importance of and impetus for carrying out early goals-of-care 
discussions with patients admitted to hospital, especially those whom have been shown to have 
high risk of death even with ICU admission https://bit.ly/2UNV6cu
The patient and family perspective on the appropriateness of intensive care unit (ICU) treatments 
involves preferences, values and social constructs beyond medical criteria. The clinician’s perception 
of inappropriateness is more reliant on clinical judgment. Earlier consultation with families before 
ICU admission and patient education on the outcomes of life-sustaining therapies may help reconcile 
these provider–patient disagreements. However, global emergencies like COVID-19 change the 
usual paradigm of end-of-life care, as it is a new disease with only scarce predictive information 
about it. Pandemics can also bring about the burdensome predicament of doctors having to make 
unwanted choices of rationing access to the ICU when demand for otherwise life-saving resources 
exceeds supply. Evidence-based prognostic checklists may guide treatment triage but the principles 
of shared decision-making are unchanged. Yet, they need to be altered with respect to COVID-19, 
defining likely outcomes and likelihood of benefit for the patient, and clarifying their willingness 
to take on the risks inherent to being in an ICU for 2 weeks for those eligible. For patients who 
are admitted during the prodrome of COVID-19 disease, or those who deteriorate in the second 
week, clinicians have some lead time in hospital to have appropriate discussions about ceilings of 
treatments offered based on severity.
Cite as: Cardona M, 
Anstey M, Lewis ET, et al. 
Appropriateness of intensive 
care treatments near the end 
of life during the COVID-19 
pandemic. Breathe 2020; 
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Review
Appropriateness of intensive care 
treatments near the end of life 
during the COVID-19 pandemic
Quality end of life and 
medicalisation of natural 
dying in the intensive care 
unit
Older patients at the end of life are often repeatedly 
admitted to hospital and require admissions to the 
intensive care unit (ICU), yet their outcomes remain 
poor, many do not survive admission and others die 
within months of ICU discharge [1, 2]. Of those that 
survive an ICU stay, their long-term quality of life and 
physical health are often severely compromised after 
hospital discharge [3]. High quality end-of-life care in 
the ICU has been defined by families as encompassing 
timely and compassionate communication, shared 
decision-making incorporating patient treatment 
goals and values, avoidance of prolongation of dying, 
and preservation of comfort and dignity [4]. Despite 
this, with increasingly available technology to prolong 
life – the medicalisation of death [5] – has resulted in 
many of these ICU admissions deemed inappropriate 
from a medical perspective [6] and in some cases, 
unwanted by the patients themselves, who would 
largely prefer less aggressive treatments at the end 
of life [7].
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Factor affecting 
clinicians’ perception 
of inappropriateness
Clinicians may generally have some understanding 
of what constitutes inappropriate care at the end 
of life [8] but there is no consensus.
Treatments are considered medically 
inappropriate due to many factors: the intensity of 
resource use is deemed to be more substantial than 
warranted [9]; patients being too ill to benefit from 
ICU management [10]; unnecessary treatments 
when there is little hope of surviving the ICU stay 
[11]; the intervention is expected to have a negligible 
impact on recovery of independence [8]; or the 
treatment having a possible adverse bearing on the 
health outcome or quality of life of the person [12]. 
Yet doctors still administer aggressive treatments 
to patients at the end of life [13], even though 
recognition of dying has occurred [14]. This may 
create confusion among patients’ and families’ 
understanding of the expected disease trajectory. It is 
then not surprising that no consensus on the patient 
or family perception of what constitutes appropriate 
admission to the ICU or appropriate treatment in 
an ICU are available either [8, 15, 16]. In some 
countries (including Australia and New Zealand), 
doctors have the right not to deliver treatment that 
they consider futile and are not obliged to seek 
consent from surrogate decision-makers or patients 
to cease inappropriate treatments [17, 18]. Instead 
they have long been considered to be first in line to 
determine appropriateness or futility of treatment 
[19] as they are, by default, acting in the best 
interest of patients. As such, families do not have 
the legal right to insist on specific interventions [20], 
although there are examples of legal cases where 
families have prevented what they consider to be 
inappropriate care, whether it is the right to continue 
or discontinue active treatment. The culture of 
setting treatment goals on behalf of patients 
without discussing alternative care pathways before 
aggressive treatments are administered has started 
to change in recent times with support for shared 
decision-making between clinicians and patients 
or their surrogates.
Patient and family 
perceptions of 
inappropriateness
The terms “inappropriate” and “futile” are generally 
not used by patients or their surrogates but a survey 
of ICU patients and their surrogates in the USA 
and Hungary reported that “too much treatment” 
was perceived as inappropriate mainly due to 
misalignment with either patient or family wishes, 
or because it caused unacceptable suffering or was 
too costly [21, 22]. In a small US veterans’ clinic 
study, elderly outpatients defined “futility” as those 
treatments administered when the patient “has 
nothing to look forward to” or “is a vegetable”, or the 
treatments are “a waste of time and money” [12]. 
Factors predisposing participants to categorise end-
of-life interventions as futile were a low likelihood 
of treatment success, a limited expected effect on 
the patient’s longevity and quality of life, and an 
anticipated emotional and financial cost to the 
family in countries where universal healthcare was 
not available [12]. Medicare beneficiaries in the USA 
(mostly older people aged ≥65 years and younger 
people with disabilities) were less likely to consider 
admission to an ICU within 30 days of death for 
patients with advanced-stage cancer as excellent 
quality of care [23]. This view was associated with 
the place of death not being consistent with the 
patient’s wishes. Perceived inappropriateness 
and lack of satisfaction with care in the ICU are 
reported to be significantly associated [21, 24]. Yet 
satisfaction may not always be a good surrogate for 
appropriateness as cognitive dissonance remained 
in other cases where survival was preferred to 
palliation and thus, aggressive care in the ICU 
was paradoxically associated with higher levels of 
surrogate satisfaction [25].
Readiness to communicate 
and accept decision making
Traditionally, the teaching has been that decisions 
about withdrawing or withholding intensive 
therapies need to be made when there is no 
longer a true prospect of benefit for the patients 
but a possibility of treatment causing more harm 
than good. Patients or families are often asked to 
participate in these decisions after a patient has 
been admitted to ICU [26, 27] but conflict over the 
end-of-life care in the ICU still occurs and strategies 
to resolve this conflict are not always successful [28]. 
Family involvement in critical decisions in the ICU 
is known to lead to psychological distress, anxiety 
and depression regardless of whether patients die or 
survive the ICU admission [29]. Increasingly, there 
is an awareness that patients are willing to accept 
some degree of suffering for a positive outcome, 
but the majority are unlikely to accept ending up in 
a dependent state [30]. Discussions with surrogate 
decision makers in the ICU should focus on these 
patient values, rather than the traditional mortality 
discussions [31].
A first step in the decision-making process is 
understanding the likely prognosis for that patient 
given their past medical history and the condition 
for which they are being treated. Ideally, wherever 
possible, current estimates of outcomes for similar 
patients are useful to create a starting point for 
the discussion of the likelihood of recovery. This 
discussion should not provide only the delivery of 
negative prognostic information to families [32], a 
Breathe | June 2020 | Volume 16 | No 2 4
End-of-life ICU treatments during the COVID-19 pandemic
practice that unfortunately, more often than not, 
involves spending more time speaking to families 
and less time listening to their concerns [33, 34]. 
The central theme of these conversations is clarifying 
the treatment goals. That is, deciding whether the 
aim of treatment is curative, palliative or terminal 
depending on the expected response and clinical 
outcomes, and giving the patient or family the 
opportunity to decline treatments if they so wish 
[35]. Lack of consultation with patients or lack of 
control over decisions on treatment, discontinuation 
by families, or inadequate communication are some 
of the main reported causes of dissatisfaction with 
ICU management (table 1).
What is different about ICU 
admission appropriateness 
in a pandemic?
Empowering people to make choices about their 
own health should become routine in the future. 
This would include, where available, giving 
prognostic information to people prior to hospital 
admission and ICU transfer [45, 46] and before the 
severity of illness takes away the patient’s ability to 
make these decisions. If this has not occurred, then 
the earlier people receive information, the better, 
as aggressive treatments may not be compatible 
with a “good death” [47].
The unprecedented escalation of patient load 
in emergency departments and ICUs associated 
with the 2019 coronavirus disease (COVID-19) 
has forced clinicians to accelerate the numbers 
of end-of-life discussions in some countries [48]. 
Furthermore, the time pressures of this worldwide 
crisis and the rapidity of the clinical progress of 
the disease means that people may be faced with 
these considerations as a matter of urgency [39]. 
While there remains medical uncertainty about 
all the potential outcomes of COVID-19, the rapid 
sharing of international experiences has already 
provided us with useful information about the 
likely outcomes for patients who end up requiring 
mechanical ventilation [49]. Reports have emerged 
of the association between older age (≥60 years) 
and higher severity of respiratory illness, more 
common development of acute respiratory distress 
and longer course of illness [50]. The outcomes 
for COVID-19 patients who require mechanical 
ventilation are much poorer than those not on 
ventilators (66.3% versus 19.4% in-hospital 
death) and there is higher mortality than from 
other types of viral pneumonia [51]. In older age 
groups and those requiring invasive ventilation, 
mortality approaches 70% [52, 53]. This calls for 
clinicians to help families understand the aim of 
limitations of treatments, and discuss potential 
futility of aggressive treatments and the need to 
ethically cease intervention [45]. For patients who 
are admitted during the prodrome of COVID-19 Ta
bl
e 
1 
D
om
ai
ns
 c
ov
er
ed
 b
y 
th
e 
de
fin
iti
on
s 
of
 p
er
ce
iv
ed
 in
ap
pr
op
ria
te
ne
ss
 o
f o
r d
is
sa
tis
fa
ct
io
n 
w
ith
 IC
U
 m
an
ag
em
en
t
Fi
rs
t 
au
th
or
 [r
ef
.]
In
co
n
si
st
en
t 
w
it
h
 p
at
ie
n
t/
fa
m
ily
 v
al
u
es
N
ot
 a
cc
ep
ti
n
g 
pr
og
n
os
is
/c
on
fl
ic
t 
w
it
h
 p
re
di
ct
io
n
La
ck
 o
f 
co
n
su
lt
at
io
n
 w
it
h
 
pa
ti
en
t/
la
ck
 o
f 
co
n
tr
ol
 b
y 
fa
m
ily
In
ad
eq
u
at
e 
co
m
m
un
ic
at
io
n#
To
o 
ag
gr
es
si
ve
/
ca
u
si
n
g 
su
ff
er
in
g
Co
st
La
ck
 o
f u
n
de
rs
ta
n
di
n
g 
of
 li
m
it
at
io
n
s 
of
 li
fe
-
su
st
ai
n
in
g 
th
er
ap
ie
s
Le
n
gt
h
y 
IC
U
 
st
ay
Q
u
an
ti
ta
ti
ve
 s
tu
di
es
 
Le
 G
u
en
 [3
6]
•
 
W
ri
gh
t 
[2
3]
•
•
•
 
W
il
so
n
 [2
1]
•
•
•
 
Yo
u
 [3
7]
•
 
Le
w
is
-N
ew
by
 [3
8]
•
•
 
G
ri
es
 [3
9]
•
•
•
 
Te
n
o
 [4
0]
•
•
•
•
 
B
re
en
 [4
1]
•
 
R
iv
er
a 
[4
2]
•
•
Q
u
al
it
at
iv
e 
st
u
di
es
 
Zi
er
 [4
3]
•
•
 
W
il
lm
o
tt
 [4
4]
•
 
W
o
rk
m
an
 [2
5]
•
•
•
 
R
o
d
ri
gu
ez
 [1
2]
•
•
•
# :
 in
cl
ud
es
 tr
ea
tm
en
t o
pt
io
ns
, c
on
se
qu
en
ce
s,
 p
re
fe
re
nc
es
, t
re
at
m
en
t g
oa
ls
 o
r v
al
ue
s.
5 Breathe | June 2020 | Volume 16 | No 2
End-of-life ICU treatments during the COVID-19 pandemic
disease or deteriorate in the second week, clinicians 
have some lead time in hospital to have appropriate 
discussions about ceilings of treatments offered 
(i.e. offer ward-based therapies, noninvasive or 
mechanical ventilation according to the patient’s 
needs, values, preferences and potential benefit).
The need to prevent transmission of infection 
between patients, relatives and healthcare workers 
has led to hospitals reducing visitor numbers [54]. 
It is possible that patients will die without any or all 
of their family and loved ones around them. In the 
meantime, some units have resorted to innovative 
solutions involving video and telephone links, but 
these remain inferior to face-to-face family meetings.
An even more burdensome predicament of 
doctors is the possible need to make unwanted 
choices of rationing access to the ICU when demand 
for life-saving resources exceeds supply. Criteria 
for ICU admission, discharge and triage have been 
in place for over two decades [16, 55, 56] and 
rely heavily on clinicians’ judgment. These have 
relied on many factors, such as the seriousness 
of the presenting illness, age, levels of frailty, the 
trajectory of a person’s deterioration, the person’s 
likelihood of benefit during and after ICU stay, 
and the attitudes and beliefs of the person being 
considered for life support in an ICU. Implicitly, local 
resource availability is also considered. Other ethical 
issues need to be considered, such as governments 
triaging the need for supportive infrastructure like 
ventilators and beds, as well as the provision of 
those resources in a fair and equitable fashion. 
Although ICU triage may be considered “business 
as usual”, given that the fluctuating demand 
may approach capacity routinely during winter 
seasons, this process is based on a belief that the 
ICU has little to offer those of advanced age with 
irreversible progressive disease. The pandemic 
triage is fundamentally different. Resources may 
not be available to manage every patient as usual 
and survival may be diminished once resources 
are exhausted, as it has been the case in previous 
influenza epidemics in some health systems 
[57]. Current European guidelines for hospital 
preparedness and management of COVID-19 
do not include refinements to ICU admission 
criteria [58] in the face of extraordinary pandemic 
demands. Various objective checklists, such as the 
Simplified Acute Physiology Score (SAPS) II and 
the Acute Physiologic Assessment and Chronic 
Health Evaluation (APACHE) II [59], can be used as 
references to determine mortality risks according 
to prognostic parameters, but tools to select and 
reject patients on the basis of ICU bed shortage are 
not tested in first-world medicine, poorly socialised 
and little understood, and will impact clinicians 
and society in ways not previously experienced 
in the developed world outside wartime. One 
suggestion is to use a multiprinciple allocation 
framework, whereby the decision makers use 
a combination of the likelihood to benefit from 
intensive care based on their illness severity, their 
comorbidities and a consideration of their life cycle 
considerations (assigning higher relative priority to 
younger patients with dependents, or healthcare 
workers) [60]. Fidelity in the administration of 
the framework is required to prevent stigma or 
disadvantage among already vulnerable groups (e.g. 
indigenous populations, the homeless and disabled 
persons) [61]. Although mechanisms for dealing 
with regional disasters exist (earthquakes, mass 
shootings, etc.) where patients can be diverted or 
retrieved to areas of increased resources to reduce 
mismatch, pandemics are unique in their ability to 
overwhelm every resource, often simultaneously. 
This process is worsened as, unlike many disease 
processes, clinical staff are at equal or higher 
risk of being affected. Even if some areas are less 
directly affected, diversion of resources such as 
personal protective equipment or ventilators to 
those overwhelmed may impact their capability to 
provide healthcare.
In an overwhelmed health system, the definition 
of appropriateness may be transformed by the scale 
of the emergency. That is, the good intentions of 
implementing shared decision making may not be 
realistic if a prior end-of-life discussion has not been 
held [36] or the resources are not there to align with 
patient expectations.
The dilemma is that not arriving at a joint 
clinician–patient decision contravenes the 
principle of patient autonomy [12] and there is 
corresponding loss of dignity [62]. The question 
emerging is whether in the midst of a pandemic 
that carries devastating economic consequences 
on the health system, there is the opportunity to 
reach satisfactory negotiation between clinicians 
and patients or families on the extent of ICU care 
to be administered, including the decision not to 
admit to the ICU to avoid prolonging suffering before 
death. The ideal situation recommended by peak 
professional bodies would be where the decision is 
neither doctor-driven nor patient/surrogate-driven 
[17] but a reconciliation of the two perspectives.
A way forward
Strategies that have been shown to reassure families 
of the appropriateness or inappropriateness of the 
ICU treatments and generate more satisfaction 
include obtaining consent [63], better step-
by-step communication updates as status and 
indications for treatment change, sufficient time 
for information exchange, consistent information, 
and knowing the role of each service provider [64]. 
While surviving the ICU to discharge is heralded as 
a “success”, even if from the patient’s perspective, 
communicating the expected long-term quality of 
life after ICU discharge may also assist families in 
making informed decisions about treatment goals 
[65]. However, it is acknowledged that these are 
early days in the history of COVID-19 to confidently 
or accurately predict long-term outcomes.
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Consultation before ICU admission, if feasible, 
could contribute to less dissatisfaction, as it is known 
that the timing of negative prognostic communication 
is associated with the preparedness of families and 
the complexity of decision making [32]. While many 
families accept recommendations for withdrawing 
or withholding treatment [66], unreasonable 
expectation of recovery still contributes to patient 
or family requests for medically inappropriate 
treatments [43], which may not be satisfied under 
current circumstances. Early and proactive palliative 
care consultations can alleviate the pressure on other 
health professionals.
Much education on the difference between 
withdrawing treatment, withholding treatment 
and allowing to die [67] is still needed to improve 
public understanding of the role and implications 
of palliative and comfort care, and the potential 
inappropriateness of ICU admission. When some 
certainty of the irreversibility of a patient’s condition 
is present, the end-of-life transition in the ICU can 
be a coordinated effort and orders for limitations 
of life-sustaining treatment must not imply 
abandonment of patient care [68].
When there are discordant opinions between 
families and health professionals, if feasible, 
decisions to admit the dying elderly for short periods 
to trial care in the ICU may be appropriate in an 
attempt to address the discordance and give time 
to families to adjust to the bad news [69]. Clinicians 
may advocate for these time-limited ICU intensive 
treatments until the prognosis is more certain or until 
differences of opinion within families are reconciled 
as families realise the treatment goals need to change 
from curative to palliative [69]. One difficulty with 
COVID-19 is for those who end up requiring intensive 
care, the median duration of treatment needs to be 
10–12 days (reported interquartile ranges 7–12 and 
10–18 days) [70, 71], which reduces the ability to 
offer “short trials” of advanced treatments. Generally, 
the median length of ICU stay including all critical 
conditions is about 2–4 days, and for pneumonia 
under nonpandemic situations, is generally around 
7 days for patients of all ages [72].
A clear ICU admission 
guideline for catastrophic 
emergencies
For over two decades, guidelines have stated 
that restricting ICU admission for the elderly 
is unethical if the decision is made only on the 
grounds of age [2, 60]. The impact of frailty and 
pre-existing comorbidities on short-term mortality 
[73] should also be considered in the algorithm. 
However, as mentioned above, data indicate that 
in the COVID-19 pandemic, advanced age and 
prognosis are directly related. Information and the 
uncertainty around prognosis have to be shared 
with patients, their carers and society in an open 
and transparent way. Urgently needed during this 
pandemic if resources were to become scarce, is a 
guiding pathway for decision making that includes 
prognostic thresholds on the likelihood of benefit 
and an end-of-life discussion about palliative care 
with families on reasonable care aligned with 
patient’s values. A good generic start could include 
the components illustrated in figure 1.
The family conference or other approaches to joint 
decision making are opportunities for reconciling 
differences of opinion and for enhancing families 
understanding of the consequences of inappropriate 
ICU care at the end of life. It is important to 
understand factors beyond religious objections 
that make surrogate decision-makers disagree 
with medical recommendations and insist on 
interventions when the chances of survival are 
Self-evaluation questions
1 Which of the following aspects of ICU inappropriate treatments is true 
for patients and families?
a. Could mean insufficient treatment
b. Can mean “too much” treatment
c. Could be interchangeable with dissatisfaction with ICU care
d. Care inconsistent with patient values
e. All the above
2 Inappropriate ICU treatments for doctors mean
a. too late to benefit
b. too costly
c. unlikely to survive
d. All the above
e. a and c only
3 Which of the following are anticipated risks during pandemics?
a. Having to ration access to the ICU without clear guidelines
b. Not having time for informed shared decision making
c. Be accused of ageism
d. Family conflict with clinicians
e. All the above
4 There is evidence that consultation with the primary caregiver or 
family decision maker can facilitate the decision not to admit a patient 
to ICU in global emergency situations.
a. True
b. False
5 Which strategy has shown to reassure families of the appropriateness 
of ICU admission and increase satisfaction?
a. Inconsistent clinical information
b. Withholding prognostic information from families
c. Uncoordinated step-by-step communication
d. Communicating expected long-term quality of life after ICU 
discharge
6 The decision-making process near end of life can include
a. providing the patient/family the opportunity to refuse treatment
b. prognostic information
c. clarifying treatment goals and personal values
d. all the above
7 Breathe | June 2020 | Volume 16 | No 2
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extremely low or the health system resources 
cannot support universal access to ICU. In the 
latter case, providing patients and families with 
this information either at admission to hospital 
or via public information campaigns may have 
some benefit in managing expectations during a 
pandemic.
Implications for practice
It is clear that using medical criteria alone for 
decision making on ICU admission at the end of life 
carries the ethical dilemma of overlooking patient 
values and preferences [74] or unintentionally 
making decisions to deny access in times of global 
emergencies. The role of the physician includes 
delivering prognostic news sensitively, helping 
families accept the imminence of death, involving 
families in decision making when the patient 
is incapacitated and coordinating healthcare 
providers in the effective application of end-of-
life-care extending to limitations of life-sustaining 
treatment [75]. This could improve by recognising 
and effectively using the informal roles of family 
members as they emerge during crisis situations. 
These have been identified as Primary Care Giver, 
Primary Decision Maker, Family Spokesperson, 
Out-of-Towner, Patient Wishes Expert, Protector, 
Vulnerable Member and Health Care Expert [76]. 
Consultation with them can minimise conflict and 
facilitate negotiations on prevention of inappropriate 
ICU admission or interventions. However, this 
has not been tested in global pandemics and in 
such situations where decision making needs to 
be expedited, wide consultation is likely not to be 
possible.
Conclusions
Perceived inappropriateness of ICU treatments for 
families and patients is multifactorial, and it involves 
social constructs beyond the medical rationale. 
Health service users appreciate consultation on their 
values and improved communication for shared 
decisions about ICU admissions and treatments, 
but their definition of inappropriateness appears 
to clash with the goal-of-treatment orientation 
of the medical perspective. Discordance between 
healthcare provider and healthcare user perceptions 
and satisfaction with end-of-life management 
in the ICU continues to be a consistent finding 
across studies. Much work lies ahead in clinicians’ 
Patient
requires ICU
resource
EOL discussion and 
apply ICU pandemic 
triage tool
Usual ICU triage
(reversibility, co-
morbidities, treatment 
burden)
Enter time-limited 
queue to wait for 
ICU resource and 
family discussion
Family discussion
and palliative care
Family discussion 
and ward-level or 
palliative care
Is ICU
admission in keeping 
with patient's wishes?
Is ICU 
resource 
available?
Meets all
inclusion and 
no exclusion 
criteria
Did ICU resource 
become available 
in time?
Admit
ICU?
Patient 
admitted to
ICU
No
No
No
No
No
Yes
Yes
Yes
Yes
Yes
Figure 1 Generic triage protocol guiding modified rules for ICU admission during global emergencies. EOL: end of life.
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understanding the family experience and consulting 
families before ICU admission to reconcile these 
differences. Admission and discharge criteria 
specific to emergencies may assist clinicians in 
allocating resources but is likely to be unpopular 
with the general population, who might be 
uncomfortable with explicit proscriptive formulas 
for determining access to ICU treatments; they 
prefer the clinical judgment of senior clinicians. 
However, those clinicians should adjust their 
decision-making approach using a combination of 
inputs, including patient values, the likelihood of 
the treatments offered achieving those outcomes, 
and the competing priorities for the ICU services to 
ensure scarce resources are diverted to those who 
both want and would benefit from them.
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